Innovator International Developed 10 Buffer ETF

Innovator International Developed 10 Buffer ETF is an actively managed exchange-traded fund sub-advised by Parametric. It seeks capital appreciation through uncapped participation in the equity markets of developed countries outside the United States and Canada, while aiming to limit losses with a series of 10% buffers against declines in the MSCI EAFE Index, measured over one-year periods before fees. The fund invests at least 80% of its net assets in equity securities and option contracts providing exposure to large- and mid-capitalization companies in international developed markets, tracking a diversified portfolio representative of the Solactive GBS Developed Markets ex North America Large & Mid Cap Index. Parametric actively monitors the equity portfolio and ladders FLEX options to protect capital. Top holdings include prominent firms like ASML Holding NV, Roche Holding AG, Novartis AG, HSBC Holdings PLC, and AstraZeneca PLC, alongside options such as EFA puts. Launched in 2026, this ETF from Innovator ETFs serves investors seeking defined outcome strategies in the EAFE region, encompassing Europe, Australasia, and the Far East, without currency hedging.